Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SNC162

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND AND PURPOSE δ Opioid receptor agonists are being developed as potential treatments for depression and alcohol use… Expand
Is this relevant?
2010
2010
Mu-opioid receptor agonists such as fentanyl are effective analgesics, but their clinical use is limited by untoward effects… Expand
Is this relevant?
2008
2008
In the present study, whole-cell patch-clamp technique was used to observe the effects of SNC162, a selective agonist of δ-opioid… Expand
Is this relevant?
2004
2004
The diarylpiperazine delta-opioid agonist SNC80 [(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3… Expand
Is this relevant?
2002
2002
The majority of reports assessing opioid drug discrimination learning (DDL) have concentrated on characterizing the stimulus… Expand
Is this relevant?
2001
2001
The effects of SNC80 and other structurally related delta-opioid receptor agonists were assessed under conditions of chemically… Expand
Is this relevant?
1999
1999
Five rhesus monkeys were trained to discriminate the nonpeptidic, d-opioid agonist SNC80 (0.32 mg/kg i.m.) from saline by using a… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1996
1996
The racemic compound (+/-)-BW373U86 ¿(+/-)-4-((alpha R*)- alpha-((2S*,5R*)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxy- benzyl… Expand
Is this relevant?